The Postage is a new company that uses technology to help ease the experience of afterlife responsibilities for family members. Photo courtesy of The Postage

Three years ago, Emily Cisek was struck with immense grief when she lost three family members back to back. She says she learned first-hand how arduous the process of wrapping up someone's life is and how it can take away from the grieving process.

"I saw the frustrations in my family," she explains, as she grappled with the passing of both her grandmothers and her cousin's young child.

Cisek says in that moment she thought, "Wow, there's got to be a better way so that people have a resource to get a plan and walk through the process so that when you do lose someone, there is a really easy way to manage that."

Cisek's realization planted a seed and she has the idea for The Postage, a digital platform that helps collect information and digital assets in one place to ease with affair planning.

She sought out to build an online platform that provides an easy path for people to plan their affairs and leave behind wishes for loved ones, making affairs management after death easier and less time-consuming. The features include document storage and organization, password management, funeral and last wishes planning, and the option to create after-life messages to posthumously share with loved ones.

Up until now, death care has been a predominantly business-to-business model. Prior to becoming the co-founder and CEO of The Postage, Emily was the Director of Sales at Integrate Agency, a full-service digital and traditional marketing agency in Texas. Her years of launching robust marketing initiatives and developing communications programs, made bringing The Postage to consumers that much easier.

She partnered with her former boss and serial entrepreneur, Robbie Wright, to build The Postage and make her vision a reality to help loved ones deal with loss.

The Postage completed funding in April of 2020, surpassing its initial fundraising goal. In total, Cisek raised $925,000 in a three month span. The platform officially launched in September, bringing a new, accessible contender to the estate planning industry.

Making death a conversation point

Everything you need on one digital platform. Photo courtesy of The Postage

According to The Institute for Healthcare Improvement, 92 percent of Americans say it's important to discuss their wishes for end-of-life care, but only 32 percent have actually had the conversation. Talking about your death plans is never an easy conversation, Cisek remarks. Her goal is to provide a methodical process that "makes it simpler."

"Until the last 100 years, death was just a part of life. Right now with technology and healthcare, it almost is seen as a weakness versus as you know, something we all experienced together," says Cisek.

Knowing how arduous these conversations are, she feels The Postage is like a "guidebook" that provides "clear-eyed compassion" to start the conversation. The site's planning options, password and document storage, and ability to share final wishes aims to make the process less emotional and difficult for users.

Accessibility for all ages

The Postage is something anyone can use. Photo courtesy of The Postage

While creating a death plan may feel like something reserved for later in life, Vox reports that millennials are becoming a "death positive" generation. More people in their 20s and 30s are planning their own funerals, donating their body to science, and contemplating how they want to pass peacefully.

From YouTube channels like "Ask a Mortician" to apps that remind you that — sorry to break it to you — you will eventually die, young creators are coping with death online. Despite the online vote of confidence in passing to the other side, dying is, well, expensive.

According to data from The Postage, estate planning and legal services can cost an average of $6,500. Cisek's company allows a monthly subscription with prices ranging from $5.99 to $9.99 a month, depending on storage space and features.

"I think the way The Postage has [made planning more available] it's provided a price point, an understanding and steps involved that are more easily accessible; no matter what age group, what race, what your background is, your religion, anything like that, you're able to sign up," says Cisek.

Digital options like password management and storage also make the site a more cost effective, approachable option for young people born into the digital era.

Saving time

Founder Emily Cisek prioritized convenience in her design. Photo courtesy of The Postage

Death puts into perspective just how valuable time can be. According to The Postage, families can expect to spend nearly 500 hours on completing end-of-life details if there is no planning done in advance. If every moment matters, 500 hours can sound like an exorbitant amount of time spent on paperwork.

From knowing who your loved one's electricity provider is to ensuring you have the key to their safety deposit box, the process can be a nightmare, says Cisek. She believes that should be spent "celebrating [their life] and processing the loss versus getting frustrated and trying to dig through things that you don't understand, and frankly, don't know what the wishes were of that person you lost."

The Postage's features allow you to drop in documents and passwords at your own pace to provide your loved ones with a smooth transition and instructions. To Cisek, she minds the site to be a guidebook that says, "This is what we need to do, and here is how I'm leaving the best gift I can for my loved ones."

National growth

The Postage went live nationally. Photo courtesy of The Postage

The Postage is a Houston-based company, but Cisek and her team want it to reach Americans everywhere.

"When we went live nationally, we actually launched over 100 new enhancements — even small, little things in the customer experience that would make it better and easier," she explains.

During its summer launch the website received 60 percent engagement and over 43 percent in new referrals. The Postage plans to continue enhancing the user experience and expanding the app with new technologies.

Cisek, bright-eyed with entrepreneurial spirit, has big hopes for the future as she imagines the opportunities. She hopes to change the way her generation plans for the future, contributing to a shift in sharing your legacy and wishes with loved ones.

"I think that technology, in recent times, has really focused on the consumer being the product versus the technology being the product," remarks Cisek. "If we're able to take that back and provide a product that truly makes our users' lives easier, the sky's the limit on what that could look like," she continues.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.